Abstract
During the past few years, hematopoietic cell culture technologies for transplantation therapies have progressed significantly on several fronts. Advances include the discoveries of the growth factors thrombopoietin and Flt-3 ligand, the development of a variety of bioreactor systems, and results from preliminary clinical trials that demonstrate the efficacy of ex vivo expanded hematopoietic cells for transplantation therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 223-230 |
Number of pages | 8 |
Journal | Current Opinion in Biotechnology |
Volume | 7 |
Issue number | 2 |
DOIs | |
State | Published - Apr 1996 |
ASJC Scopus subject areas
- Biotechnology
- Bioengineering
- Biomedical Engineering